Spinout from the Igtp for neurodegenerative rare diseases.
Biointaxis has raised €3.0M across 3 funding rounds from 5 investors. Based in Barcelona, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| — | Other | — | — | View deal → |
| 2024-10-23 | Other | €2.2M | European Commission,Ministry of Science, Innovation and Universities | View deal → |
| 2021-11-03 | Other | €880k | Antonio Parente,Capital Cell,Private Investors | View deal → |
